Xiao-Ping Qi

Dr. Xiao-Ping Qi


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XQXiao-Ping Qi
Xiao-Ping Qi
JMJu-Ming Ma
Ju-Ming Ma
ZDZhen-Fang Du
Zhen-Fang Du
RYRong-Biao Ying
Rong-Biao Ying
JFJun Fei
Jun Fei
XZXianning Zhang
Xianning Zhang
Whole exome sequencing provides a labor-saving and direct means of genetic diagnosis of hereditary disorders in which the pathogenic gene harbors a large cohort of exons. We set out to demonstrate a suitable example of genetic diagnosis of MEN 2A/FMTC (multiple endocrine neoplasia type 2/familial medullary thyroid carcinoma) using this approach. We sequenced the whole exome of six individuals from a large Chinese MEN2A/FMTC pedigree to identify the variants of the RET (REarranged during Transfection) protooncogene and followed this by validation. Then prophylactic or surgical thyroidectomy with modified or level VI lymph node dissection and adrenalectomy were performed for the carriers. The cases were closely followed up. Massively parallel sequencing revealed four missense mutations of RET. We unexpectedly discovered that the proband's daughter with MEN 2A-related MTC presented a novel p.C634Y/V292M/R67H/R982C compound mutation, due to the involvement of p.C634Y in the proband with MEN 2A and p.V292M/R67H/R982C in the proband's husband with FMTC. In the maternal origin, p.C634Y caused bilateral MTC in all 5 cases and bilateral pheochromocytoma in 2 of the 5; the earliest onset age was 28 years. In the paternal origin, one of the six p.V292M/R67H/R982C carriers presented bilateral MTC (70 years old), one only had bilateral C-cell hyperplasia (44 years), two had bilateral multi-nodules (46 and 48 years) and two showed no abnormality (22 and 19 years). The results confirmed the successful clinical utility of whole exome sequencing, and our data suggested that the p.C634Y/V292M/R67H/R982C mutation of RET exhibited a more aggressive clinical phenotype than p.C634Y or p.V292M/R67H/R982C, while p.V292M/R67H/R982C presented a relatively milder pathogenicity of MTC and likely predisposed to FMTC.

22 August 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
XQXiao-Ping Qi
Xiao-Ping Qi
JZJian-Qiang Zhao
Jian-Qiang Zhao
ZCZhen-Guang Chen
Zhen-Guang Chen
JCJin-Lin Cao
Jin-Lin Cao
JDJuan Du
Juan Du
JMJu-Ming Ma
Ju-Ming Ma
RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D

30 September 2013 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
XQXiao-Ping Qi
Xiao-Ping Qi
JZJ-Q. Zhao
J-Q. Zhao
ZDZ-F. Du
Z-F. Du
RYR-R. Yang
R-R. Yang
JMJ-M. Ma
J-M. Ma
XZXianning Zhang
Xianning Zhang

7 February 2018 in Cancer Investigation
Verified
Journal Article
Closed access
XQXiao-Ping Qi
Xiao-Ping Qi
JZJian-Qiang Zhao
Jian-Qiang Zhao
ZCZhi-Lie Cao
Zhi-Lie Cao
EFEr Fu
Er Fu
FLFeng Li
Feng Li
HJHong Jia
Hong Jia
This study systematically reviewed previous literatures and analyzed the genotype–phenotype relationship between the multiple endocrine neoplasia type 2A (MEN 2A)-cutaneous lichen amyloidosis (CLA) and RET/OSMR/IL31RA mutations. RET/OSMR/IL31RA screening was performed on 8 RET-carriers from 3 independent Chinese MEN 2A families. Besides, 51 MEN 2A-CLA patients in 116 RET carriers from literatures were clustered and analyzed. Our results indicated that almost all MEN 2A-CLA patients exhibited CLA which was located in the scapular region and carried RET mutation at codon 634. Meanwhile, we firstly described MEN 2A-CLA here in Chinese Han patient with RET p.C634F mutation.

9 November 2011 in Familial Cancer
Verified
Journal Article
Closed access
PDF file
XQXiao-Ping Qi
Xiao-Ping Qi
RYR.-B. Ying
R.-B. Ying
JMJ.-M. Ma
J.-M. Ma
WLW.-T. Liu
W.-T. Liu
ZDZ.-F. Du
Z.-F. Du
XZXianning Zhang
Xianning Zhang

11 May 2017 in Journal of Biosciences
Verified
Journal Article
Closed access
PDF file
ZDZhen-Fang Du
Zhen-Fang Du
PLPeng-Fei Li
Peng-Fei Li
JZJian-Qiang Zhao
Jian-Qiang Zhao
ZCZhi-Lie Cao
Zhi-Lie Cao
FLFeng Li
Feng Li
XQXiao-Ping Qi
Xiao-Ping Qi